Latest Breaking News On - World congress on acute heart failure - Page 1 : comparemela.com

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024

Cardiol Therapeutics Inc : Cardiol Therapeutics Announces Phase II ARCHER Trial Presented at the World Congress on Acute Heart Failure 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesDavid elsleyCarsten tschTrevor burnsCardiol therapeutics incNewsfile corpDrug administrationBerlin institute of healthWorld congress on acute heart failureCompany annual report on formPilot phaseWorld congressAcute heart failureHeart failure associationEuropean societyBerlin institute

Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis

Cardiol Therapeutics surpasses 85% enrollment in ARCHER trial for acute myocarditis
proactiveinvestors.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from proactiveinvestors.com Daily Mail and Mail on Sunday newspapers.

United statesDavid elsleyCarsten tschBerlin institute of healthWorld congress on acute heart failureCardiol therapeuticsWorld congressAcute heart failureBerlin institutePilot phase

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

United statesSan franciscoRecardio incWorld congressWorld congress on acute heart failureAcute myocardial infarctionLatebreaker sessionAcute heart failureEfficacy studyDutogliptinin combinationPrincipal investigator dirkMedical universityMyocardial infarctionRelease servicePositive phase

Recardio s Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid

Recardio s Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

The Week Ahead In Biotech (May 22-28): Verrica, Bristol-Myers Squibb FDA Decisions, Medtronic Earnings, Conference Presentations & More

Biotech stocks advanced in the week ending May 22, defying the broader market retreat. The defensive nature of the industry and stock-specifi.

New yorkUnited statesSan diegoMiami beachBioequity europeCytokinetics incorporatedBristol myers squibb companyProtagonist therapeutics incHeart failure congressGeovax labs incCymabay therapeutics incPfizer incVerrica pharmaceuticals incEuropean society of cardiologyAbbvie incRegeneron pharmaceuticals inc